Benefit for patient and society
Our results will not only lead to a better treatment of patients, but also to avoidance of unnecessary treatment.
The use of new targeted therapeutic modalities will lead to a significant cost increase for the Dutch health care system. However, several reports have shown that administration of targeted therapies based on genetic analysis of the patients’ tumor leads to a more rational use of these costly drugs by avoiding treatment of patients that will not benefit from these therapies. The selective use of targeted drugs by selection of those patients that benefit most will be required to make the new treatment of cancer affordable for the Dutch healthcare system.
We see this as our strongest contribution to society. In addition, we feel we also have an important task in education and communication, as detailed in the next paragraphs.
Mobile DNA-lab ‘Read the language of the tumor’
In the current high school curriculum, DNA is an important yet rather isolated topic that pupils often perceive as complex and highly abstract. In order to introduce modern DNA-research to schools and to make pupils acquainted with current genomics topics and their implications for society, the CGC has developed a mobile DNA-lab that is offered free of charge to all secondary schools (4-6 havo/vwo) in the Netherlands. The 4hr educational modules contain a 2hr practical lab taught at the schools by university students with up-to-date genomics equipment and techniques.
The pupils are given the role of DNA-researchers and are asked to compare DNA from cancer cells of a (fictive) patient with DNA of healthy cells. Based on their results, they have to advise the physician on the optimal treatment of this particular patient. The module was developed in collaboration with the Freudenthal Institute for Science Education of Utrecht University in line with the recommendations of the Committee Innovation Biology Education (‘Commissie Vernieuwing Biologie Onderwijs’) regarding the context-concept approach. Since its start in September 2005, the DNA-lab has reached over 40,000 secondary school students in het Netherlands.
Teachers can obtain additional information and register at www.dnalabs.nl
The mobile DNA-lab is further supported by information on cancer and genomics on the website www.allesoverdna.nl (in Dutch). Here teachers and pupils can find teaching materials and tests to prepare for the school exam.
12 Jan 2018
annual CGC meeting 2018
All CGC.nl researchers are welcome, however registration is required.
28 Nov 2017
ERC grant for Michiel Vermeulen
Michiel Vermeulen, one of our CGC group leaders, was awarded a prestigious ERC-Consolidator Grant.Read more >
17 Nov 2017
Fumagalli wins CGC poster prize
Arianna Fumagalli received the 2017 poster award during the CGC meeting New Horizons in Cancer ResearchRead more >
More News >
10 & 11 Jan 2019
CGC-Oncode annual scientific meeting
Annual meeting for the CGC and Oncode scientific community
08 & 09 Nov 2018
CGC-Oncode annual conference
Oncode and the Cancer Genomics Centre are pleased to host our annual joint scientific meeting at the KIT Royal Tropical Institute in Amsterdam. This year's topic is “From tissues to cells to molecules: multi-scale visualization of cancer processes”. More information is available here
05 Oct 2018
MASSterclass: Spectrometry & Cytometry
By Michiel Vermeulen and Yvonne Vercoulen Oncode Institute and CGC host a workshop about quantitative mass spectrometry-based proteomics and mass cytometry. What do you need to run a smooth experiment? Which kind of research questions can be answered? What are the costs? By the end of the workshop you will know what is needed to execute a succesful mass spectrometry or cytometry experiment. Please register here
More Events >